For those of you planning to get sick this winter, make sure you budge for it first. In recent times, illness hasn’t just taken a toll on our health, though of course is the primary focus.
There is also a major financial burden to getting sick. This includes a loss of income and expensive medications, which may not be fully (or even partially) covered by insurance or financial aid programs.
It is said that chronic diseases are normally the most expensive and, with that, cancer is in a class by itself. Researchers at an international medical conference in Malaysia have presented findings which show cancer’s financial toll is not limited to the United States, but even to countries that provide free health care.
According to Consumer Affairs, this study determined that more than half of cancer survivors spend at least a third of their yearly income on treatment and associated costs. They are often required to pay for cancer drugs that are not funded by the government.
While these study results were based on the situation in Malaysia, health officials attending the conference said it is common throughout the world. Whatever kind of health care system a country has, citizens who get cancer face severe financial hardships, what the Malaysian researchers called “financial toxicity.”
“The loss of work, a carer’s income and early retirement can all contribute to the financial burden on the household,” said lead author Anupriya Agarwal, a cancer specialist from Sydney, Australia. “Our study aims to provide insight into these costs and assist policymakers in finding ways of reducing this burden on patients.”
Part of the expense lies in the cost of the drugs that treat cancer. It has been well-documented that some drug companies have significantly raised the price of older cancer treatment drugs without making any improvements to them. But new and effective cancer drugs are even more expensive.
Last year Drugwatch.com reported that a new Bristol Myers Squibb cancer drug that was shown to be highly effective against melanoma will cost $141,000 for the first 12 weeks of treatment and $256,000 for a year of treatment.
The American Cancer Society says patients are generally hit with costs for doctor visits, lab tests, clinic visits for treatment, imaging tests, radiation treatments, drug costs, hospital stays, surgery and home care. Insurance plans might not cover all of these costs.
To help patients plan, the American Cancer Society offers these tips.